ORAL TOXICITY/ COMPLICATIONS FOLLOWING BONE MARROW TRANSPLANTS
骨髓移植后的口腔毒性/并发症
基本信息
- 批准号:3795007
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:bone marrow transplantation cancer complication cancer pain combination cancer therapy disease /disorder proneness /risk drug adverse effect gender difference graft versus host disease human age group human subject neoplasm /cancer chemotherapy neoplasm /cancer radiation therapy oral bacteria oral facial pain oral health oral pharyngeal disorder oral pharyngeal disorder diagnosis radiobiology statistics /biometry tobacco abuse
项目摘要
Oral Complications are not only a major cause of pain and suffering for
patients undergoing marrow transplantation (BMT), but can also contribute
to systemic complications and fatality. Many factors cause or influence
the severity of BMT oral complications, including chemoradiotherapy
conditioning regimens, oral infections, and acute and chronic GVHD. Little
is known about which factors acting singly or in combination are most
damaging to oral tissues; the clinical recognition and diagnosis of some
complications is unclear, the types and frequency of risks associated with
the presence of these complications has yet to be determined. There have
been no reported studies on how acute GVHD is manifested in the mouth.
Oral acute GVHD frequently goes undetected or is misdiagnosed which can
result in delayed diagnosis, compromise overall patient management and lead
to increased suffering and risk of other complications. Similar problems
exist for oral toxicities resulting from chemoradiotherapy and from oral
microbial colonization and infection. We will examine factors likely to
influence the frequency and severity of oral complications following BMT.
These will include; a) patient-related factors such as patient age,
disease, previous therapy, pretransplant oral health, numbers and types of
dental restorations and appliances, and oral habits (including smoking) and
b) BMT-related factors such as the type and dosage of agents used in BMT
conditioning regimens, the use of biological response modifiers, post-BMT
immunosuppressive therapy, the rate of engraftment, oral microbial
colonization and types of infections, including viral infections, and acute
GVHD. The investigators will study these factors through a) the review of
prior medical records and medical history, b) frequent detailed clinical
examinations, and c) specific laboratory (pathology, microbiology,
chemistry, etc.) data. They expect to: a) determine the contribution
various risk factors make to the various oral complications observed; b)
develop useful diagnostic criteria for diagnosing oral complications of
BMT; and c) thus determine oral complication risk profiles for patients.
Besides facilitating more expeditious diagnosis of oral complications,
these studies will aid in the design of oral care protocols to more
efficiently and effectively prevent and/or manage oral problems. They will
also enhance understanding of how oral complications can cause or influence
systemic complications following BMT.
口腔并发症不仅是造成疼痛和痛苦的主要原因
接受骨髓移植(BMT)的患者,但也可以做出贡献
导致全身并发症和死亡。 许多因素造成或影响
BMT 口腔并发症的严重程度,包括放化疗
调理方案、口腔感染以及急性和慢性 GVHD。 小的
已知哪些因素单独或组合作用最重要
损害口腔组织;某些疾病的临床识别和诊断
并发症尚不清楚,相关风险的类型和频率
这些并发症的存在尚未确定。 有
目前尚无关于急性 GVHD 如何在口腔中表现的研究报道。
口腔急性 GVHD 经常未被发现或被误诊,这可能会导致
导致诊断延迟,损害整体患者管理并导致
增加痛苦和其他并发症的风险。 类似问题
存在因放化疗和口服引起的口服毒性
微生物定植和感染。 我们将研究可能的因素
影响 BMT 后口腔并发症的发生频率和严重程度。
这些将包括; a) 患者相关因素,例如患者年龄,
疾病、既往治疗、移植前口腔健康、数量和类型
牙齿修复和矫治器以及口腔习惯(包括吸烟)和
b) BMT相关因素,例如BMT所用药物的类型和剂量
调理方案、生物反应调节剂的使用、BMT 后
免疫抑制治疗、植入率、口腔微生物
定植和感染类型,包括病毒感染和急性感染
移植物抗宿主病。 研究人员将通过以下方式研究这些因素:a) 审查
先前的医疗记录和病史,b) 频繁的详细临床
检查,以及 c) 特定实验室(病理学、微生物学、
化学等)数据。 他们期望: a) 确定贡献
各种危险因素导致观察到的各种口腔并发症; b)
制定有用的诊断标准来诊断口腔并发症
骨髓移植; c) 从而确定患者的口腔并发症风险状况。
除了促进口腔并发症的更快速诊断之外,
这些研究将有助于设计更多的口腔护理方案
高效且有效地预防和/或管理口腔问题。 他们会
还可以增强对口腔并发症如何导致或影响的了解
BMT 后的全身并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M SCHUBERT其他文献
M SCHUBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M SCHUBERT', 18)}}的其他基金
PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
- 批准号:
2579598 - 财政年份:
- 资助金额:
-- - 项目类别:
MULTITARGET RIBOZYMES AS ANALYTICAL AND THERAPEUTIC AGENTS
多靶点核酶作为分析剂和治疗剂
- 批准号:
2579665 - 财政年份:
- 资助金额:
-- - 项目类别:
PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
- 批准号:
6163049 - 财政年份:
- 资助金额:
-- - 项目类别:
ORAL TOXICITY/ COMPLICATIONS FOLLOWING BONE MARROW TRANSPLANTS
骨髓移植后的口腔毒性/并发症
- 批准号:
3772762 - 财政年份:
- 资助金额:
-- - 项目类别:
PSEUDOTYPIC DEFECTIVE INTERFERING HIV PARTICLES AS AN ANTIVIRAL THERAPY FOR AIDS
假型缺陷干扰 HIV 颗粒作为艾滋病抗病毒疗法
- 批准号:
3782407 - 财政年份:
- 资助金额:
-- - 项目类别:
MULTITARGET RIBOZYMES AS ANALYTICAL AND THERAPEUTIC AGENTS
多靶点核酶作为分析剂和治疗剂
- 批准号:
5204025 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
白血病患儿生精功能的保存与重建
- 批准号:81071899
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
BIOBEHAVIORAL INTERVENTIONS FOR ORAL PAIN AND MUCOSITIS
口腔疼痛和粘膜炎的生物行为干预
- 批准号:
6186834 - 财政年份:1995
- 资助金额:
-- - 项目类别: